Home › ABL Successfully Completes Drug Product Manufacture Of Ebola Vaccine For Clinical Trial
 

Keywords :   


ABL Successfully Completes Drug Product Manufacture Of Ebola Vaccine For Clinical Trial

2015-07-01 08:22:45| drugdiscoveryonline Home Page

ABL, Inc. (ABL), a contract research and manufacturing organization to the biopharmaceutical industry, is pleased to announce the successful aseptic formulation and fill of an Ebola vaccine candidate for Emergent BioSolutions Inc. (EMERGENT)

Tags: product trial drug successfully

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Sheboygan Paint Company Appoints New Technical Sales Representative
20.05GK Hair Unveils Summer 2024s Must-Have Hair Trends
20.05Revlon Taps Under Armour\'s Tchernavia Rocker As New Chief People Officer
20.05Canada invests over $9.6M to prevent, prepare for African swine fever
20.05Dabbagh Named General Manager of Waldencast Ventures Glaze Brand
20.05Pretty Little Thing warned over 'misleading' ads
20.05Several pork priorities secured in House Farm Bill
20.05BT scraps digital landline switch deadline
More »